Company intelligence / Profile preview
Incepta Vaccine
- Ownership
- Private
- Development stage
- Other
Overview
Incepta Vaccine Ltd is the first Bangladeshi company to acquire technology to manufacture human vaccines locally, with a portfolio of 12 vaccines (including oral cholera, hepatitis B, rabies, meningococcal ACYW135, tetanus, among others), and an active pipeline featuring HPV, PCV, dengue, and rotavirus vaccines; most launched products are approved and marketed domestically and exported[1][3][4][5][7].
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineInactivated vaccineLive attenuated vaccineSubunit vaccineRecombinant vaccinePolysaccharide vaccineConjugate vaccineToxoid vaccine
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Incepta Vaccine.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Incepta Vaccine.